Brown Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
551,207
-39,807
| -7% | -$742K | 0.3% | 46 |
|
|
2025
Q1 | $11.3M | Sell |
591,014
-51,006
| -8% | -$977K | 0.34% | 50 |
|
|
2024
Q4 | $23.1M | Sell |
642,020
-97,076
| -13% | -$3.5M | 0.54% | 44 |
|
|
2024
Q3 | $31.3M | Sell |
739,096
-175,359
| -19% | -$7.44M | 0.67% | 38 |
|
|
2024
Q2 | $36.8M | Sell |
914,455
-40,112
| -4% | -$1.62M | 0.74% | 36 |
|
|
2024
Q1 | $33.8M | Buy |
954,567
+219,940
| +30% | +$7.79M | 0.6% | 39 |
|
|
2023
Q4 | $21.7M | Sell |
734,627
-829,915
| -53% | -$24.5M | 0.33% | 41 |
|
|
2023
Q3 | $32.5M | Sell |
1,564,542
-27,187
| -2% | -$565K | 0.5% | 38 |
|
|
2023
Q2 | $39.1M | Sell |
1,591,729
-579,044
| -27% | -$14.2M | 0.55% | 36 |
|
|
2023
Q1 | $88.2M | Buy |
2,170,773
+155,374
| +8% | +$6.31M | 1.32% | 27 |
|
|
2022
Q4 | $90.6M | Buy |
2,015,399
+5,169
| +0.3% | +$232K | 1.5% | 25 |
|
|
2022
Q3 | $96.2M | Buy |
2,010,230
+317,416
| +19% | +$15.2M | 1.35% | 27 |
|
|
2022
Q2 | $100M | Buy |
1,692,814
+473,867
| +39% | +$28M | 1.34% | 29 |
|
|
2022
Q1 | $142M | Buy |
1,218,947
+30,299
| +3% | +$3.52M | 1.41% | 26 |
|
|
2021
Q4 | $179M | Sell |
1,188,648
-35,118
| -3% | -$5.29M | 1.48% | 26 |
|
|
2021
Q3 | $146M | Sell |
1,223,766
-2,350
| -0.2% | -$281K | 1.2% | 29 |
|
|
2021
Q2 | $119M | Sell |
1,226,116
-3,186
| -0.3% | -$310K | 0.91% | 34 |
|
|
2021
Q1 | $108M | Buy |
1,229,302
+6,093
| +0.5% | +$538K | 0.81% | 37 |
|
|
2020
Q4 | $117M | Buy |
1,223,209
+4,468
| +0.4% | +$428K | 0.81% | 33 |
|
|
2020
Q3 | $138M | Sell |
1,218,741
-1,105
| -0.1% | -$125K | 1.15% | 27 |
|
|
2020
Q2 | $121M | Buy |
1,219,846
+110,463
| +10% | +$10.9M | 1.04% | 28 |
|
|
2020
Q1 | $71.4M | Buy |
1,109,383
+199,391
| +22% | +$12.8M | 0.83% | 32 |
|
|
2019
Q4 | $54.2M | Buy |
+909,992
| New | +$54.2M | 0.52% | 36 |
|